Hayat Pharmaceutical Co. PLC   Report issue

For profit Phase 3 Phase 4
Founded: Milwaukee WI United States (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2014
NCT02328404
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

HAYAT PHARMACEUTICAL INDUSTRIES CO. PLC

Active Ingredients

Drugs in Phase 4 Trials (1)

serratiopeptidase (1 trial)

Drugs in Phase 3 Trials (1)

vitamin d3 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Avitaminosis (Phase 3)

Inflammation (Phase 4)

Overweight (Phase 3)

Polycystic Ovary Syndrome (Phase 3)

Rickets (Phase 3)

Syndrome (Phase 3)

Trismus (Phase 4)

Vitamin D Deficiency (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 2